Raymond Douglas, MD
Ophthalmology · Beverly Hills, CANPI 1124041959
Payments from drug & device makers
Across 326 payments — averaging $29,889 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$9.7M
- Vertical Pharmaceuticals, LLC$15K
- Kedrion Biopharma, Inc.$2K
- AbbVie$311
- Genentech USA, Inc.$144
- Galderma Laboratories, L.p.$143
- plus $84 from 2 others
What the payments were for
- Consulting fees$480,13538%
- Speaking & faculty fees$270,82321%
- Grants$465,95237%
- Travel & lodging$44,6344%
- Food & beverage$5,0760%
- Education$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 309 | $9,725,878 |
| Vertical Pharmaceuticals, LLC | 2 | $15,050 |
| Kedrion Biopharma, Inc. | 8 | $2,253 |
| AbbVie | 3 | $311 |
| Genentech USA, Inc. | 1 | $144 |
| Galderma Laboratories, L.p. | 1 | $143 |
| Stryker | 1 | $84 |
| Travere Therapeutics, Inc. | 1 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$1,097,946
- KRYSTEXXA$27,300
- Albuked$2,172
- KOATE$2,172
- GAMMAKED$2,172
- KEDRAB$2,172
- RhoGAM Ultra-Filtered PLUS$2,172
- VUITY$148
- Erivedge$144
- BOTOX COSMETIC$141
How this compares
$9,743,864 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Beverly Hills
- Stuart StollBeverly Hills$673K
- Nisha AcharyaSan Francisco$33M
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Sherif El HaraziGlendale$9.2M
- Daniel SchwartzSan Francisco$8M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
- Steven JacobsonLos Angeles$4.7M
- Peter WinArcadia$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.